Stay on top of the gene therapy market

gene therapies in various 418 stages of development of commercialization in late 2015, from 162 originating companies.The number of gene therapy x2 products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015 Cancer is the most common target for products, followed by monogenic diseases.
Read more...

;